Rankings
▼
Calendar
BHVN Q1 2019 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena
BHVN
Biohaven Ltd.
$1B
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$54M
Net Income
-$62M
EPS (Diluted)
$-1.41
Cash Flow
Operating Cash Flow
-$47M
Free Cash Flow
-$48M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$245M
Total Liabilities
$148M
Stockholders' Equity
$97M
Cash & Equivalents
$217M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$54M
-$83M
+34.7%
Net Income
-$62M
-$85M
+27.1%
← FY 2019
All Quarters
Q2 2019 →